Steve Clifford
Steve Clifford
Director, Newcastle University Centre for Cancer
Verified email at ncl.ac.uk - Homepage
Title
Cited by
Cited by
Year
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
PH Maxwell, MS Wiesener, GW Chang, SC Clifford, EC Vaux, ...
Nature 399 (6733), 271-275, 1999
49471999
Molecular subgroups of medulloblastoma: the current consensus
MD Taylor, PA Northcott, A Korshunov, M Remke, YJ Cho, SC Clifford, ...
Acta neuropathologica 123 (4), 465-472, 2012
12122012
Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
ME Cockman, N Masson, DR Mole, P Jaakkola, GW Chang, SC Clifford, ...
Journal of Biological Chemistry 275 (33), 25733-25741, 2000
11902000
Medulloblastoma comprises four distinct molecular variants
PA Northcott, A Korshunov, H Witt, T Hielscher, CG Eberhart, S Mack, ...
Journal of clinical oncology 29 (11), 1408, 2011
10332011
Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas
M Kool, A Korshunov, M Remke, DTW Jones, M Schlanstein, PA Northcott, ...
Acta neuropathologica 123 (4), 473-484, 2012
6892012
Dissecting the genomic complexity underlying medulloblastoma
DTW Jones, N Jäger, M Kool, T Zichner, B Hutter, M Sultan, YJ Cho, ...
Nature 488 (7409), 100-105, 2012
6722012
Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features
M Kool, J Koster, J Bunt, NE Hasselt, A Lakeman, P Van Sluis, D Troost, ...
PloS one 3 (8), 2008
6642008
Subtypes of medulloblastoma have distinct developmental origins
P Gibson, Y Tong, G Robinson, MC Thompson, DS Currle, C Eden, ...
Nature 468 (7327), 1095-1099, 2010
6382010
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
PA Northcott, DJH Shih, J Peacock, L Garzia, AS Morrissy, T Zichner, ...
Nature 488 (7409), 49-56, 2012
6082012
β-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee
DW Ellison, OE Onilude, JC Lindsey, ME Lusher, CL Weston, RE Taylor, ...
Journal of Clinical Oncology 23 (31), 7951-7957, 2005
4222005
Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups
DW Ellison, J Dalton, M Kocak, SL Nicholson, C Fraga, G Neale, ...
Acta neuropathologica 121 (3), 381-396, 2011
4052011
Contrasting effects on HIF-1α regulation by disease-causing pVHL mutations correlate with patterns of tumourigenesis in von Hippel-Lindau disease
SC Clifford, ME Cockman, AC Smallwood, DR Mole, ER Woodward, ...
Human molecular genetics 10 (10), 1029-1038, 2001
3992001
Inactivation of the von Hippel–Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: Evidence for a VHL‐independent …
SC Clifford, AH Prowse, NA Affara, CHCM Buys, ER Maher
Genes, Chromosomes and Cancer 22 (3), 200-209, 1998
3021998
Definition of disease-risk stratification groups in childhood medulloblastoma using combined clinical, pathologic, and molecular variables
DW Ellison, M Kocak, J Dalton, H Megahed, ME Lusher, SL Ryan, W Zhao, ...
Journal of clinical oncology 29 (11), 1400, 2011
2672011
Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma
N Zhukova, V Ramaswamy, M Remke, E Pfaff, DJH Shih, DC Martin, ...
Journal of Clinical Oncology 31 (23), 2927, 2013
2612013
Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis
UK Tyne
Cell Cycle 5 (22), 2666-2670, 2006
2452006
Combined histopathological and molecular cytogenetic stratification of medulloblastoma patients
JM Lamont, CS McManamy, AD Pearson, SC Clifford, DW Ellison
Clinical Cancer Research 10 (16), 5482-5493, 2004
2352004
Risk stratification of childhood medulloblastoma in the molecular era: the current consensus
V Ramaswamy, M Remke, E Bouffet, S Bailey, SC Clifford, F Doz, M Kool, ...
Acta Neuropathologica, 2016
2132016
Cytogenetic prognostication within medulloblastoma subgroups
DJH Shih, PA Northcott, M Remke, A Korshunov, V Ramaswamy, M Kool, ...
Journal of clinical oncology 32 (9), 886, 2014
2072014
Hyperfractionated versus conventional radiotherapy followed by chemotherapy in standard-risk medulloblastoma: results from the randomized multicenter HIT-SIOP PNET 4 trial
B Lannering, S Rutkowski, F Doz, B Pizer, G Gustafsson, A Navajas, ...
Journal of clinical oncology 30 (26), 3187-3193, 2012
2062012
The system can't perform the operation now. Try again later.
Articles 1–20